General Anesthesia Drugs Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

General anesthesia is a therapeutically induced condition of unconsciousness; that is, loss of protective reflexes, which results from the use of one or multiple general anesthetic agents. The drug is administered to allow performing the medical procedures which are unbearably painful for the patient. A range of medicines can be administered, the overall aim of which is to ensure unconsciousness, analgesia, and loss of reflexes of the ANS or autonomic nervous system. In some cases, general anesthetic drugs are used for paralyzing the skeletal muscles.

Presently, there is a lack of consistency of technique in the general anesthetic field. Anesthesiologists have a preference for using one or a mixture of drugs. This choice depends upon the choice and experience of the physician or surgeon and the physiological state in which the patient is in. General anesthesia drugs are utilized in a number of surgeries. The general anesthesia drugs market is likely to be boosted by the rising number of surgeries including orthopedic, general surgeries, cardiac, and others throughout the globe. Moreover, advancements in the anesthesia drug delivery methods, such as jet injection, inhalation and computer controlled anesthesia delivery systems will further encourage the general anesthesia drugs industry. Nevertheless, lack of proper health care facilities especially in the underdeveloped countries as well as in remote areas, presence of few anesthetists and certified nurse per capita of population are likely to inhibit the growth of the general anesthesia drugs market.

General anesthesia drugs market Taxonomy

On the basis of product type,

  • Propofol
  • Dexmedetomidine
  • Sevoflurane
  • Desflurane
  • Midazolam
  • Others

On the basis of route of administration,

  • Injection
  • Inhalation

High growth in the number of surgeries and rise in geriatric population will drive the overall general anesthesia drugs market

The increasing volume of surgical procedures across the globe is likely to drive the overall growth of the anesthesia drugs market in the forecast period. Anesthesia is used during different surgical procedures which are conducted to manage various diseases including gastrointestinal diseases, cardiovascular diseases, spinal abnormalities, urological disorders, orthopedic deformities, and brain tumors. The significant growth in the number of surgeries, especially in the European countries will help in the growth of the general anesthesia drugs market in this region. For example, the amount of laparoscopic colostomy surgeries tripled in Spain and doubled in Slovenia between 2008 and 2014.  Different types of surgeries performed in various ASCs or ambulatory surgical centers include hernia procedure, cervix and uterus removal, transurethral excision, lens and cataract, and hysterectomy. The increase in geriatric population as well as the growth in the number of surgeries will fuel the growth of the general anesthesia drugs market in the near future.

By geography, North America held the maximum share of general anesthesia drugs market in 2016 and is projected to continue its dominance during the forecast period. The rising demand for propofol is one of the primary causes for this dominance of the North America market, especially the U.S. Moreover, the rising focus by a significant number of manufacturers to explore new routes of administration such as topical and oral will boost adoption of anesthetic drugs in the overall market. The rising demand for anesthesia in labor patients is anticipated to propel the market growth as well. According to a report by Centers for Disease Control and Prevention (CDC), around 3,984,502 deliveries including caesarean and vaginal took place in 2016 in the U.S.

The major players operating in the global general anesthesia drugs market are Baxter, B. Braun, AbbVie, Aspen, Fresenius Kabi, Arbor Pharmaceuticals, Air Liquide, Avera Pharmaceuticals, GSK, Eisai, Jiangsu HengRui Medicine, Lannett Company, Johnson & Johnson, Merck, Mydent International, Nuvo Pharmaceuticals, Novalar Pharma, Paion UK, Primex Pharmaceuticals, Pfizer,St. Renatus, The Medicines Company, and Takeda.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.
Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.